Table 1.
Diagnostic Tool | Sensitivity | Specificity | Pros | Cons |
---|---|---|---|---|
Symptom Screening | Variable, up to 93% | Variable | Cheap, easy to implement | Large tradeoff between sensitivity and specificity, performance depends on setting |
Chest X-ray | 73–95% | 63% | Already implemented in many centers, cheap to perform | Requires expertise to interpret, high inter-observer variability |
Sputum Microscopy | 60% | 95% | Cheap | Time consuming, low sensitivity in HIV coinfection |
Solid Media Culture | Reference standard | Reference standard | Cheap | Requires significant lab infrastructure, requires up to 8 weeks |
IGRA* | 69–83% | 52–61% | Does not require sputum | Poor performance for active disease |
Fluorescence Microscopy | 70% | 95% | Higher sensitivity and faster than conventional microscopy | Requires specialized equipment |
Liquid Media Culture | 10% more than solid media | Reference standard | Faster than solid media but still requires weeks | Specialized equipment and highly trained technicians |
PCR* | 10–100% | 5–100% | Rapid turn-around, most are highly specific | Expensive, highly variable performance, need highly trained personnel |
Xpert MTB/RIF | 89% | 99% | Rapid turn-around, good performance in HIV positive, moderately priced, rifampin resistance testing included | Unclear impact on mortality |
LPA* | 66–95% | 99% | Can be performed directly on patient samples | Expensive |
IGRA – Interferon-gamma release assay, PCR – Polymerase chain reaction, LPA - Line Probe Assay